|
|
Learning Objective:
By the end of the presentation participants will be able to assess the effectiveness of a centralized state-based case management program for HBsAg positive pregnant women.
Background:
In the US approximately 20,000 infants are born to women who are hepatitis B surface antigen (HBsAg) positive. These infants are at high risk of acquiring HBV infection and the associated HBV complications. Vaccine advisory groups recommend that all pregnant women be routinely tested for HBsAg during and early prenatal visit and that newborns born to women who are HBsAg positive receive appropriate prophylaxis because prophylaxis is approximately 90% effective. The State of Connecticut Department of Public Health established a centralized perinatal hepatitis B case management program in 1992.
Setting:
Connecticut
Population e.g. API Youth, MSM, IDU:
Women identified as HBsAg positive and pregnant, her newborn, children, sex partner(s) and household contacts.
Project Description:
A nurse consultant implements a centralized state-based case management system that included the identification, contact, interview and follow-up of pregnant HBsAg positive women. Data is tracked using EpiInfoV6. This program requires collaboration with providers, hospitals, DPH Immunizations Program, local health departments, and the families/significant others involved. Pregnant women and their infants are followed to ensure that HBIG and the birth dose of the hepatitis B vaccine is given within the first 12 hours of life and that the hepatitis B vaccine series is completed by 9 months of age. Post vaccine testing on infants is encouraged. Siblings, household contacts and then sex partners are followed as time allows.
Results/Lessons Learned:
Data analysis, results and lessons learned from the first 1278 cases (1992 –2003). Analysis includes outcome data [number of women reported and delivered, follow-up data (receipt of HBIG, hepatitis B vaccination dose timing, completed, lost to follow, moved out-of-state, infants positive after birth, and the number and results of infants who were tested post vaccination)].
See more of Poster Session #1
See more of The 2005 National Viral Hepatitis Prevention Conference